ERBB2 and cancer: Though ddPCR has not yet been validated by consensus guidelines, several recent studies have shown that ddPCR has excellent correlation with immunohistochemistry or fluorescence in situ hybridization for the determination of HER2 status on large tissue sections of formalin-fixed cancer samples [5, 6].